FUP.F - Fuji Pharma Co., Ltd.

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Fuji Pharma Co., Ltd.

7-3 Sanbancho
6F, Sugar Center Chiyoda-ku
Tokyo 102-0075
81 3 3556 3344

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees1,527

Key Executives

NameTitlePayExercisedYear Born
Takayuki IwaiPres & CEON/AN/AN/A
Mr. Atsuya MitsuhashiGen. Mang. of Sales Division and Exec. OfficerN/AN/A1971
Mr. Masayuki KozawaManaging Exec. Officer & Gen. Mang. of R&D DivisionN/AN/A1954
Mr. Seiichi InoueManaging Exec. Officer, GM of Corp. Division & Standing Corp. AuditorN/AN/A1958
Mr. Toyoyuki KamideExec. Officer and DirectorN/AN/A1965
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers hormone medicines for obstetrics and gynecology therapies, as well as injectable drugs, such as radiopharmaceutical products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. The company was founded in 1965 and is headquartered in Tokyo, Japan.

Corporate Governance

Fuji Pharma Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.